Effect of prostaglandin and bisphosphonate on cancellous bone volume and structure in the ovariectomized rat studied by quantitative three-dimensional nuclear magnetic resonance microscopy

Journal of Bone and Mineral Research

Volumn 14, Issue 5, 1999, Pages 680-689

  Takahashi, Masaya ^a   Wehrli, Felix W ^a   Wehrli, Suzanne L ^b   Hwang, Scott N ^a   Lundy, Mark W ^c   Hartke, Jim ^c   Borah, Babul ^c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c Health Care Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PROSTAGLANDIN; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCELLOUS BONE; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFECT; MONITORING; MORPHOMETRICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; QUANTITATIVE ASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THICKNESS; TRABECULAR BONE;

ALENDRONATE; ANIMALS; BONE AND BONES; DINOPROSTONE; DIPHOSPHONATES; FEMALE; GADOLINIUM DTPA; MAGNETIC RESONANCE SPECTROSCOPY; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 0032898398     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.5.680     Document Type: Article

References (42)

1. Thompson DD, Simmons HA, Pirie CM, Ke HZ 1995 FDA guidelines and animal models for osteoporosis. Bone 17 (Suppl 4):125S-133S.
2. Mosekilde L 1995 Assessing bone quality - Animal models in preclinical osteoporosis research. Bone 17 (Suppl 4):S343-S352.
3. Kalu DN 1991 The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-191.
4. Westerlind KC, Wronski TJ, Ritman EL, Luo ZP, An KN, Bell NH, Turner RT1997 Estrogen regulates the rate of bone turn-over but bone balance in ovariectomized rats is modulated by prevailing mechanical strain. Proc Natl Acad Sci USA 94:4199-4204.
5. Qi H, Li M, Wronski TJ 1995 A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. J Bone Miner Res 10:948-955.
6. 2 increased rat cortical bone mass when administered immediately following ovariectomy. Bone Miner 21:189-201.
7. Frolik CA, Bryant HU, Black EC, Magee DE, Chandrasekhar S 1996 Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: Effects of raloxifene HCI, tamoxifen, estrogen, and alendronate. Bone 18:621-627.
8. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kauffman RF, Bensch WR, et al. 1994 Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63-69.
9. Genant HK, Block JE, Steiger P, Glüer CC, Ettinger B, Harris ST 1989 Appropriate use of bone densitometry. Radiology 170:817-822.
10. Mazess RB, Barden HS 1988 Bone densitometry for diagnosis and monitoring osteoporosis. Crit Rev Clin Lab Sci 24:217-233.
11. Recker RR 1993 Architecture and vertebral fracture. Calcif Tissue Int 53 (Suppl 1):S139-S142.
12. Parfitt AM 1992 Implications of architecture for the pathogenesis and prevention of vertebral fracture. Bone 13:S41-S47.
13. Delmas PD 1988 Biochemical markers of bone turnover in osteoporosis. In: Riggs B, Melton L (eds.) Osteoporosis -Etiology, Diagnosis, and Management. Raven Press, New York, NY, U.S.A., pp. 297-316.
14. Wahner HW, Fogelman I 1994 The Evaluation of Osteoporosis: Dual-Energy X-ray Absorptiometry in Clinical Practice. University Press, Cambridge, U.K., pp. 268-275.
15. Genant H, Ettinger B, Harris S, Block J, Steiger P 1988 Quantitative computed tomography in assessment of osteoporosis. In: Riggs B, Melton L (eds.) Osteoporosis - Etiology, Diagnosis, and Management. Raven Press, New York, NY, U.S.A., pp. 221-249.
16. Singh M, Nagarath AR, Maini PS 1970 Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg 52A:457-467.
17. Feldkamp LA, Goldstein SA, Parfitt AM, Jesion G, Kleerekoper M 1989 The direct examination of three-dimensional bone architecture in vitro by computed tomography. J Bone Miner Res 4:3-11.
18. Bonse U, Busch F, Gunnewig O, Beckmann F, Pahl R, Delling G, Hahn M, Graeff W 1994 3D computed X-ray tomography of human cancellous bone at 8 microns spatial and 10 (-4) energy resolution. Bone Miner 25:25-38.
19. Kinney JH, Lane NE, Haupt DL 1995 In vivo, three-dimensional microscopy of trabecular bone. J Bone Miner Res 10:264-270.
20. Rüegsegger P, Koller B, Muller RM 1996 A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int 58:24-29.
21. Ma J, Wehrli FW, Song HK 1996 Fast 3D large-angle spin-echo imaging (3D FLASE). Magn Reson Med 35:903-910.
22. Majumdar S, Newitt D, Mathur A, Osman D, Gies A, Chiu E, Lotz J, Kinney J, Genant H 1996 Magnetic resonance imaging of trabecular bone structure in the distal radius: Relationship with X-ray tomographic microscopy and biomechanics. Osteoporos Int 6:376-385.
23. Gordon CL, Webber CE, Christoforou N, Nahmias C 1997 In vivo assessment of trabecular bone structure at the distal radius from high-resolution magnetic resonance images. Med Physics 24:585-593.
24. Wehrli FW, Hwang SN, Ma J, Song HK, Ford JC, Haddad JG 1998 Cancellous bone volume and structure in the forearm: Noninvasive assessment with MR microimaging and image processing [published erratum appears in Radiology 1998 June, 207:833]. Radiology 206:347-357.
25. Kapadia RD, High WB, Soulleveld HA, Bertolini D, Sarkar SK 1993 Magnetic resonance microscopy in rat skeletal research. Magn Reson Med 30:247-250.
26. Wehrli FW, Ford JC, Chung HW, Wehrli SL, Williams JL, Grimm MJ, Kugelmass SD, Jara H 1993 Potential role of nuclear magnetic resonance for the evaluation of trabecular bone quality. Calcif Tissue Int 53 (Suppl 1):S162-S169.
27. Chung HW, Wehrli FW, Williams JL, Kugelmass SD, Wehrli SL 1995 Quantitative analysis of trabecular microstructure by 400 MHz nuclear magnetic resonance imaging. J Bone Miner Res 10:803-811.
28. Chung HW, Wehrli FW, Williams JL, Wehrli SL 1995 Three-dimensional nuclear magnetic resonance microimaging of trabecular bone. J Bone Miner Res 10:1452-1461.
29. Hwang SN, Wehrli FW, Williams JL 1997 Probability-based structural parameters from 3D NMR images as predictors of trabecular bone strength. Med Physics 24:1255-1261.
30. Proffitt D, Rosen R 1979 Metrication errors and coding efficiency of chain-encoding schemes for the representation of lines and edges. Comp Graph Image Process 10:318-332.
31. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis: Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409.
32. Chung H, Wehrli FW, Williams JL, Kugelmass SD 1993 Relationship between NMR transverse relaxation, trabecular bone architecture and strength. Proc Natl Acad Sci USA 90:10250-10254.
33. Frost HM, Jee WS 1992 On the rat model of human osteopenias and osteoporoses [review]. Bone Miner 18:227-236.
34. Narita Y 1995 Effect of intermittent administration of human PTH on experimental osteopenia in adult rat: A histomorphometric study of both trabecular and cortical bone of the vertebrae. J Jpn Orthopaed Assoc 69:1027-1036.
35. 2 prevents ovariectomy-induced cancellous bone loss in rats. Bone Miner 19:45-62.
36. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA 1991 Bisphosphonate action: Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:2095-2105.
37. Seedor JG, Quartuccio HA, Thompson DD 1991 The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats. J Bone Miner Res 6:339-346.
38. Jeal W, Barradell LB, McTavish D 1997 Alendronate: A review of its pharmacological properties and therapeutic efficacy in postmenopausal osteoporosis. Drugs 53:415.
39. Bone HG, Downs RW Jr, Tucci JR, Harris ST, Weinstein RS, Licata AA, McClung MR, Kimmel DB, Gertz BJ, Hale E, Polvino WJ 1997 Dose-response relationships for alendronate treatment in osteoporotic elderly women: Alendronate Elderly Osteoporosis Study Centers. J Clin Endocrinol Metab 82:265-274.
40. Tucci J, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora AC 1996 Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial]. Am J Med 101:488-501.
41. Dempster DW, Birchman R, Xu R, Lindsay R, Shen V 1995 Temporal changes in cancellous bone structure of rats immediately after ovariectomy. Bone 16:157-161.
42. Odgaard A, Andersen K, Melsen F, Gundersen HJ 1990 A direct method for fast three-dimensional serial reconstruction. J Microsc 159:335-342.